These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 9764325)

  • 21. Combination of sodium stibogluconate and rifampicin in post kala-azar dermal leishmaniasis.
    Sharma VK; Prasad HR; Sethuraman G; Khaitan BK
    Indian J Dermatol Venereol Leprol; 2007; 73(1):53-4. PubMed ID: 17314452
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study.
    Das S; Mandal R; Rabidas VN; Verma N; Pandey K; Ghosh AK; Kesari S; Kumar A; Purkait B; Lal CS; Das P
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005060. PubMed ID: 27776123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-kala-azar dermal leishmaniasis--an unusual presentation.
    Lakhanpal S; Pandhi RK; Khaitan BK
    Acta Derm Venereol; 1998 Sep; 78(5):353-4. PubMed ID: 9779253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.
    Ganguly S; Saha P; Chatterjee M; Roy S; Ghosh TK; Guha SK; Kundu PK; Bera DK; Basu N; Maji AK
    PLoS Negl Trop Dis; 2015; 9(10):e0004138. PubMed ID: 26485704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.
    Islam S; Kenah E; Bhuiyan MA; Rahman KM; Goodhew B; Ghalib CM; Zahid MM; Ozaki M; Rahman MW; Haque R; Luby SP; Maguire JH; Martin D; Bern C
    Am J Trop Med Hyg; 2013 Aug; 89(2):345-53. PubMed ID: 23817330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A male preponderance in patients with Indian post kala-azar dermal leishmaniasis is associated with increased circulating levels of testosterone.
    Mukhopadhyay D; Mukherjee S; Ghosh S; Roy S; Saha B; Das NK; Chatterjee M
    Int J Dermatol; 2016 May; 55(5):e250-5. PubMed ID: 26536363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratitis After Post-Kala-Azar Dermal Leishmaniasis.
    Pradhan A; Basak S; Chowdhury T; Mohanta A; Chatterjee A
    Cornea; 2018 Jan; 37(1):113-115. PubMed ID: 29040115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of Post-kala-azar dermal leishmaniasis.
    Ono H; Ghoreishi M; Yokozeki H; Katayama I; Nishioka K
    J Dermatol; 1998 Feb; 25(2):118-20. PubMed ID: 9563280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis.
    Thakur CP; Narain S; Kumar N; Hassan SM; Jha DK; Kumar A
    Ann Trop Med Parasitol; 1997 Sep; 91(6):611-6. PubMed ID: 9425363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
    Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
    J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis.
    Zijlstra EE; el-Hassan AM; Ismael A
    Am J Trop Med Hyg; 1995 Apr; 52(4):299-305. PubMed ID: 7741164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India.
    Das VN; Pandey K; Singh D; Forwood C; Lal CS; Das P
    J Postgrad Med; 2013; 59(3):226-8. PubMed ID: 24029204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.
    Hasnain G; Shomik MS; Ghosh P; Rashid MO; Hossain S; Hamano S; Mondal D
    Am J Trop Med Hyg; 2016 Dec; 95(6):1383-1385. PubMed ID: 27672208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.
    Ritmeijer K; Veeken H; Melaku Y; Leal G; Amsalu R; Seaman J; Davidson RN
    Trans R Soc Trop Med Hyg; 2001; 95(6):668-72. PubMed ID: 11816442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and laboratory study of kala-azar in children in Nepal.
    Singh K; Singh R; Parija SC; Faridi MM; Bhatta N
    J Trop Pediatr; 1999 Apr; 45(2):95-7. PubMed ID: 10341503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profiling of Sudanese visceral leishmaniasis patients pre- and post-treatment with sodium stibogluconate.
    Salih MAM; Fakiola M; Lyons PA; Younis BM; Musa AM; Elhassan AM; Anderson D; Syn G; Ibrahim ME; Blackwell JM; Mohamed HS
    Parasite Immunol; 2017 Jun; 39(6):. PubMed ID: 28370072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corneal complications following Post Kala-azar Dermal Leishmaniasis treatment.
    Maruf S; Nath P; Islam MR; Aktar F; Anuwarul A; Mondal D; Basher A
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006781. PubMed ID: 30222747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.
    Trindade MA; Silva LL; Braz LM; Amato VS; Naafs B; Sotto MN
    BMC Infect Dis; 2015 Nov; 15():543. PubMed ID: 26592919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.